dr erin bohula may - 'at the limits of lipid management – statins to pcsk9 inhibitors'
Published 5 years ago • 447 plays • Length 26:44Download video MP4
Download video MP3
Similar videos
-
2:54
high cholesterol and statins
-
15:24
pcsk9 and ezetimibe-non statin agents for dyslipidemia | dr. pc manoria | the interview
-
3:43
esc 2018: camellia-timi 61 - dr erin bohula
-
2:22
dr. scherber discusses ruxolitinib failure in myelofibrosis
-
4:08
beijing family seeks neuroblastoma treatment at children's hospital los angeles
-
3:56
rosuvastatin tablets: uses, dosage, mechanism, side effects, and important advice | mediinsights
-
29:34
metabolic obesity: a new therapeutic target forcardiometabolic risk reduction | dr p c manoria
-
1:12:10
cv risk in statin-treated patients with elevated triglycerides (deepak l bhatt, md) november 7, 2019
-
13:08
oral pcsk9 inhibitor - safety and efficacy in hypercholesterolemia with dr. ballantyne
-
0:20
what economic impact will biosimilars have in health care?
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial
-
1:07
dr. garcia on the tolerability of navitoclax/ruxolitinib in myelofibrosis
-
2:48
dr. nancy l. lewis explains the implications of the grid study
-
4:32
pcsk9 inhibitors for acute coronary syndrome
-
2:09
statin use study and heart surgery
-
0:54
when should a patient see a clinical lipidologist?
-
2:51
bio dr. beall
-
2:25
efficacy of varnimcabtagene autoleucel in patients with r/r bcl with no indication for car-t therapy
-
2:17
the main culprits: unraveling diabetes' top causes
-
10:56
why you need to let your doctor be the expert
-
32:00
shedding light on primary vitreoretinal lymphoma